Loading stock data…
Loading stock data…
US$244.11
Get one email when ABBV crosses your level. Checked every 15 minutes during market hours.
▼ -0.67 (-0.27%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
RSI (14-day)
55.2
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
6.59
Bearish momentumMACD below its signal line (8.19).
50-day average
226.22
Price aboveShort-term trend reference.
200-day average
223.17
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
Healthcare · Drug Manufacturers - General
AbbVie Inc. is a research-based biopharmaceutical company that discovers, develops, manufactures, and commercializes innovative medicines and therapies worldwide. The company maintains a strong focus on immunology, offering treatments like Humira, Skyrizi, and Rinvoq for autoimmune and inflammatory conditions in rheumatology, gastroenterology, dermatology, and related areas. In oncology, it provides therapies such as Imbruvica, Venclexta, Elahere, Epkinly, and Emrelis targeting blood cancers, ly…
www.abbvie.com9 strong buy · 22 buy · 8 hold · 0 sell · 0 strong sell (39 analysts, 2026-07-01)
9 strong buy · 22 buy · 9 hold · 0 sell · 0 strong sell (40 analysts, 2026-06-01)
8 strong buy · 22 buy · 10 hold · 0 sell · 0 strong sell (40 analysts, 2026-05-01)
7 strong buy · 21 buy · 11 hold · 0 sell · 0 strong sell (39 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-06-18 | 1.59 | 1.58 | ✗ Miss |
| 2026-04-28 | 4.82 | 4.97 | ✓ Beat |
| 2026-04-20 | 0.83 | 0.92 | ✓ Beat |
| 2026-03-30 | -0.65 | -0.68 | ✗ Miss |
| 2026-02-04 | 2.65 | 2.71 | ✓ Beat |
Companies in the same industry, via Finnhub
| Ex-dividend date | Amount | Payment date |
|---|---|---|
| 2026-04-15 | 1.73 | — |
| 2026-01-16 | 1.73 | — |
| 2025-10-15 | 1.64 | — |
| 2025-07-15 | 1.64 | — |
| 2025-04-15 | 1.64 | — |
| 2025-01-15 | 1.64 | — |
| 2024-10-15 | 1.55 | — |